Pet Bird Health Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
The Global Pet Bird Health Market was valued at USD 726.8 million in 2024 and is estimated to grow at a CAGR of 8.2% to reach USD 1.6 billion by 2034, propelled by the increasing recognition of avian health conditions and the adoption of preventative care approaches by bird owners and veterinarians alike. With more people seeking early diagnosis for avian ailments, there has been a noticeable uptick in the use of imaging technologies, non-invasive diagnostics, and behavioral assessments. As preventive care becomes more mainstream, advancements in diagnostics, nutritional science, and avian medicine continue to transform how bird health is managed globally.
Increased interest in comprehensive wellness care fuels demand for specialized supplements, targeted treatments, and personalized veterinary strategies tailored to various bird species. Technological tools now assist with early disease detection, improving bird longevity and overall quality of life. Telehealth solutions and mobile veterinary services bridge care gaps, especially in remote regions. Educational outreach focused on pet bird husbandry helps in driving awareness, leading to higher treatment adherence and better living conditions for companion birds. Collectively, these factors are sustaining the market’s upward trajectory.
The pharmaceuticals segment led the market with USD 348.7 million in 2024, reflecting the growing need to manage a range of avian bacterial and fungal infections. This segment continues to see innovation in drug formats-from oral treatments to topical formulations, which are delivering better therapeutic results. The growing number of certified avian veterinarians is increasing prescriptions, prompting pharmaceutical firms to broaden their product offerings. Additionally, antiparasitic and nutritional therapies specifically designed for birds are gaining traction in the market.
Parasitic infestations held a 40.8% share in 2024, underscoring their widespread impact on pet bird health. Both internal and external parasites continue to pose threats to avian wellness. Conditions caused by intestinal worms and protozoa often result in appetite loss, digestive issues, and weakened immunity. Rising awareness about these risks has led to greater use of anti-parasitic solutions, including medicated feeds, topical agents, and preventative supplements.
U.S. Pet Bird Health Market generated USD 272.9 million in 2024, supported by rising pet bird ownership, improved access to veterinary care, and increasing consumer focus on preventative wellness. With more owners seeking insurance for pet birds, routine checkups and diagnostics are becoming standard. The availability of bird health products through online retail channels expands consumer reach.
Companies like Vetnil, IDEXX, Vetafarm, Virbac, Merck & Co., INDICAL BIOSCIENCE, AdvaCare Pharma, Wildlife Computers, VioVet, CJ Wildlife, Thermo Fisher Scientific, HomeoPet, and Pranidhi Veterinary Diagnostics are strengthening their foothold by developing species-specific solutions, launching e-commerce platforms, and expanding veterinary education programs. Many invest in avian R&D to produce more effective treatments while collaborating with veterinary professionals to refine product delivery and improve animal outcomes.
Companies Mentioned
AdvaCare Pharma, Bimeda, CJ Wildlife, Hidrolab, HomeoPet, IDEXX, INDICAL BIOSCIENCE, Meadow's Animal Healthcare, Merck & Co., Pranidhi Veterinary Diagnostics, Thermo Fisher Scientific, Vetafarm, vetagenix, Vetnil, VioVet, Virbac, Wildlife Computers, Zhejiang Pushkang Biotechnology
Increased interest in comprehensive wellness care fuels demand for specialized supplements, targeted treatments, and personalized veterinary strategies tailored to various bird species. Technological tools now assist with early disease detection, improving bird longevity and overall quality of life. Telehealth solutions and mobile veterinary services bridge care gaps, especially in remote regions. Educational outreach focused on pet bird husbandry helps in driving awareness, leading to higher treatment adherence and better living conditions for companion birds. Collectively, these factors are sustaining the market’s upward trajectory.
The pharmaceuticals segment led the market with USD 348.7 million in 2024, reflecting the growing need to manage a range of avian bacterial and fungal infections. This segment continues to see innovation in drug formats-from oral treatments to topical formulations, which are delivering better therapeutic results. The growing number of certified avian veterinarians is increasing prescriptions, prompting pharmaceutical firms to broaden their product offerings. Additionally, antiparasitic and nutritional therapies specifically designed for birds are gaining traction in the market.
Parasitic infestations held a 40.8% share in 2024, underscoring their widespread impact on pet bird health. Both internal and external parasites continue to pose threats to avian wellness. Conditions caused by intestinal worms and protozoa often result in appetite loss, digestive issues, and weakened immunity. Rising awareness about these risks has led to greater use of anti-parasitic solutions, including medicated feeds, topical agents, and preventative supplements.
U.S. Pet Bird Health Market generated USD 272.9 million in 2024, supported by rising pet bird ownership, improved access to veterinary care, and increasing consumer focus on preventative wellness. With more owners seeking insurance for pet birds, routine checkups and diagnostics are becoming standard. The availability of bird health products through online retail channels expands consumer reach.
Companies like Vetnil, IDEXX, Vetafarm, Virbac, Merck & Co., INDICAL BIOSCIENCE, AdvaCare Pharma, Wildlife Computers, VioVet, CJ Wildlife, Thermo Fisher Scientific, HomeoPet, and Pranidhi Veterinary Diagnostics are strengthening their foothold by developing species-specific solutions, launching e-commerce platforms, and expanding veterinary education programs. Many invest in avian R&D to produce more effective treatments while collaborating with veterinary professionals to refine product delivery and improve animal outcomes.
Companies Mentioned
AdvaCare Pharma, Bimeda, CJ Wildlife, Hidrolab, HomeoPet, IDEXX, INDICAL BIOSCIENCE, Meadow's Animal Healthcare, Merck & Co., Pranidhi Veterinary Diagnostics, Thermo Fisher Scientific, Vetafarm, vetagenix, Vetnil, VioVet, Virbac, Wildlife Computers, Zhejiang Pushkang Biotechnology
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Industry 360° synopsis
CHAPTER 3 INDUSTRY INSIGHTS
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising awareness of avian health and welfare
3.2.1.2 Increase in bird adoption and exotic pet trends
3.2.1.3 Advances in avian diagnostics and therapeutics
3.2.2 Industry pitfalls and challenges
3.2.2.1 Limited availability of species-specific veterinary drugs
3.2.2.2 High treatment costs and low insurance penetration for birds
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Trump administration tariffs
3.5.1 Impact on trade
3.5.1.1 Trade volume disruptions
3.5.1.2 Retaliatory measures
3.5.2 Impact on the Industry
3.5.2.1 Supply-side impact (raw materials)
3.5.2.1.1 Price volatility in key materials
3.5.2.1.2 Supply chain restructuring
3.5.2.1.3 Production cost implications
3.5.2.2 Demand-side impact (selling price)
3.5.2.2.1 Price transmission to end markets
3.5.2.2.2 Market share dynamics
3.5.2.2.3 Consumer response patterns
3.5.3 Key companies impacted
3.5.4 Strategic industry responses
3.5.4.1 Supply chain reconfiguration
3.5.4.2 Pricing and product strategies
3.5.4.3 Policy engagement
3.5.5 Outlook and future considerations
3.6 Future market trends
3.7 Porter's analysis
3.8 PESTEL analysis
CHAPTER 4 COMPETITIVE LANDSCAPE, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
CHAPTER 5 MARKET ESTIMATES AND FORECAST, BY PRODUCTS AND SERVICES, 2021-2034 ($ MN)
5.1 Key trends
5.2 Pharmaceuticals
5.2.1 Drugs
5.2.2 Vaccines
5.2.3 Nutritional supplements
5.3 Diagnostics and monitoring
5.3.1 Diagnostic equipment
5.3.2 Monitoring devices
5.3.3 Consumables
5.4 Services
CHAPTER 6 MARKET ESTIMATES AND FORECAST, BY APPLICATION, 2021-2034 ($ MN)
6.1 Key trends
6.2 Parasitic infestations
6.3 Bacterial infections
6.4 Other applications
CHAPTER 7 MARKET ESTIMATES AND FORECAST, BY END USE, 2021-2034 ($ MN)
7.1 Key trends
7.2 Veterinary hospitals and clinics
7.3 Pet bird owners (home care)
7.4 Aviaries and bird sanctuaries
7.5 Other end use
CHAPTER 8 MARKET ESTIMATES AND FORECAST, BY REGION, 2021-2034 ($ MN)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
CHAPTER 9 COMPANY PROFILES
9.1 AdvaCare Pharma
9.2 Bimeda
9.3 CJ Wildlife
9.4 Hidrolab
9.5 HomeoPet
9.6 IDEXX
9.7 INDICAL BIOSCIENCE
9.8 Meadow's Animal Healthcare
9.9 Merck & Co.
9.10 Pranidhi Veterinary Diagnostics
9.11 Thermo Fisher Scientific
9.12 Vetafarm
9.13 vetagenix
9.14 Vetnil
9.15 VioVet
9.16 Virbac
9.17 Wildlife Computers
9.18 Zhejiang Pushkang Biotechnology
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Industry 360° synopsis
CHAPTER 3 INDUSTRY INSIGHTS
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising awareness of avian health and welfare
3.2.1.2 Increase in bird adoption and exotic pet trends
3.2.1.3 Advances in avian diagnostics and therapeutics
3.2.2 Industry pitfalls and challenges
3.2.2.1 Limited availability of species-specific veterinary drugs
3.2.2.2 High treatment costs and low insurance penetration for birds
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Trump administration tariffs
3.5.1 Impact on trade
3.5.1.1 Trade volume disruptions
3.5.1.2 Retaliatory measures
3.5.2 Impact on the Industry
3.5.2.1 Supply-side impact (raw materials)
3.5.2.1.1 Price volatility in key materials
3.5.2.1.2 Supply chain restructuring
3.5.2.1.3 Production cost implications
3.5.2.2 Demand-side impact (selling price)
3.5.2.2.1 Price transmission to end markets
3.5.2.2.2 Market share dynamics
3.5.2.2.3 Consumer response patterns
3.5.3 Key companies impacted
3.5.4 Strategic industry responses
3.5.4.1 Supply chain reconfiguration
3.5.4.2 Pricing and product strategies
3.5.4.3 Policy engagement
3.5.5 Outlook and future considerations
3.6 Future market trends
3.7 Porter's analysis
3.8 PESTEL analysis
CHAPTER 4 COMPETITIVE LANDSCAPE, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
CHAPTER 5 MARKET ESTIMATES AND FORECAST, BY PRODUCTS AND SERVICES, 2021-2034 ($ MN)
5.1 Key trends
5.2 Pharmaceuticals
5.2.1 Drugs
5.2.2 Vaccines
5.2.3 Nutritional supplements
5.3 Diagnostics and monitoring
5.3.1 Diagnostic equipment
5.3.2 Monitoring devices
5.3.3 Consumables
5.4 Services
CHAPTER 6 MARKET ESTIMATES AND FORECAST, BY APPLICATION, 2021-2034 ($ MN)
6.1 Key trends
6.2 Parasitic infestations
6.3 Bacterial infections
6.4 Other applications
CHAPTER 7 MARKET ESTIMATES AND FORECAST, BY END USE, 2021-2034 ($ MN)
7.1 Key trends
7.2 Veterinary hospitals and clinics
7.3 Pet bird owners (home care)
7.4 Aviaries and bird sanctuaries
7.5 Other end use
CHAPTER 8 MARKET ESTIMATES AND FORECAST, BY REGION, 2021-2034 ($ MN)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
CHAPTER 9 COMPANY PROFILES
9.1 AdvaCare Pharma
9.2 Bimeda
9.3 CJ Wildlife
9.4 Hidrolab
9.5 HomeoPet
9.6 IDEXX
9.7 INDICAL BIOSCIENCE
9.8 Meadow's Animal Healthcare
9.9 Merck & Co.
9.10 Pranidhi Veterinary Diagnostics
9.11 Thermo Fisher Scientific
9.12 Vetafarm
9.13 vetagenix
9.14 Vetnil
9.15 VioVet
9.16 Virbac
9.17 Wildlife Computers
9.18 Zhejiang Pushkang Biotechnology
